Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17037834 | 0.97 | SIGMAR1 (0.52) | SIGMAR1CA12CA2CA9TAAR1 | |
| SCHEMBL11145951 | 0.95 | CA12 (0.47) | SIGMAR1CA12CA2CA9TAAR1 | |
| SCHEMBL94623 | 0.91 | NPC1 (0.49) | SIGMAR1CA12CA2CA9 | |
| SCHEMBL11044440 | 0.89 | CA12 (0.50) | SIGMAR1CA12CA2CA9TAAR1 | |
| SCHEMBL23504507 | 0.89 | SIGMAR1 (0.46) | SIGMAR1CA12CA2CA9TAAR1 | |
| SCHEMBL6501802 | 0.89 | NPC1 (0.51) | SIGMAR1 | |
| SCHEMBL94910 | 0.89 | NPC1 (0.51) | SIGMAR1 | |
| SCHEMBL21916561 | 0.89 | NPC1 (0.51) | SIGMAR1 | |
| SCHEMBL10490549 | 0.89 | NPC1 (0.51) | SIGMAR1 | |
| SCHEMBL21337225 | 0.89 | NPC1 (0.51) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11034796-B1 | Poly(arylamine)s and uses thereof | CORNELL UNIVERSITY (US) | 2021-06-15 | — | — | US | disclosed |
| US-11034796-B1 | Poly(arylamine)s and uses thereof | CORNELL UNIVERSITY (US) | 2021-06-15 | — | — | US | disclosed |
| EP-2018848-B2 | Hair composition comprising at least one fluorescent dye and at least one alkali hydroxide agent and method of simultaneous styling, dyeing and/or lightening. | ORÉAL L (FR) | 2016-08-31 | — | — | EP | disclosed |
| US-7601180-B2 | Use for the dyeing with lightening effect of keratin substances of a composition comprising a fluorescent cyanine dye | L'OREAL S.A. (FR) | 2009-10-13 | — | — | US | disclosed |
| US-7601180-B2 | Use for the dyeing with lightening effect of keratin substances of a composition comprising a fluorescent cyanine dye | L'OREAL S.A. (FR) | 2009-10-13 | — | — | US | disclosed |
| US-20090049621-A1 | USE FOR THE DYEING WITH LIGHTENING EFFECT OF KERATIN SUBSTANCES OF A COMPOSITION COMPRISING A FLUORESCENT CYANINE DYE | L'OREAL S.A. (FR) | 2009-02-26 | — | — | US | disclosed |
| US-20090049621-A1 | USE FOR THE DYEING WITH LIGHTENING EFFECT OF KERATIN SUBSTANCES OF A COMPOSITION COMPRISING A FLUORESCENT CYANINE DYE | L'OREAL S.A. (FR) | 2009-02-26 | — | — | US | disclosed |
| EP-2018848-A2 | Hair composition comprising at least one fluorescent dye and at least one alkali hydroxide agent and method of simultaneous styling, dyeing and/or lightening. | L'Oreal (FR) | 2009-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090049621-A1 | USE FOR THE DYEING WITH LIGHTENING EFFECT OF KERATIN SUBSTANCES OF A COMPOSITION COMPRISING A FLUORESCENT CYANINE DYE | KRT18, S100A4, S100P | SIGMAR1 3481/4885CA12 1125/4885CA2 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.